secwatch / observer
8-K filed August 14, 2025, 7:59 PM ET ticker CLNN CIK 0001822791
earnings confidence high sentiment neutral materiality 0.70

Clene Inc. (CLNN): debt financing — Clene reports Q2 net loss $7.4M, cash $7.3M, plans NDA submission for CNM-Au8 in ALS by end of 2025

Clene Inc.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.95

Clene Inc. incurred convertible notes of $1,500,000 aggregate principal amount with AE Capital Limited; A Global Chorus Foundation; Glenn and Shelina Way at 12% per annum, interest capitalized and added to principal balance maturing earlier of 18 months from closing or Change in Control.

Instrument
convertible notes
Principal
$1,500,000 aggregate principal amount
Counterparty
AE Capital Limited; A Global Chorus Foundation; Glenn and Shelina Way
Rate
12% per annum, interest capitalized and added to principal balance
Maturity
earlier of 18 months from closing or Change in Control
Event
incurrence
Exact text from the filing
On August 13, 2025, the Company entered into a note purchase agreement (the “August 2025 Note Purchase Agreement”) by and among the Company and AE Capital Limited, A Global Chorus Foundation and Glenn and Shelina Way (together with AE Capital Limited and A Global Chorus Foundation, the “August 2025 Note Purchasers”), pursuant to which the Company agreed to sell, and the August 2025 Note Purchasers agreed to purchase, the Company’s senior secured convertible promissory notes (collectively, the “ August 2025 Notes”) in a principal amount totaling $1,500,000.
View on SEC.gov
Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.95

Clene Inc. amended convertible notes of original principal amounts unchanged (December 2024 Notes); monthly principal repayments of $1,000,000 per month deferre with Kensington Clene 2024, LLC; 4Life Research, LLC; La Scala Investments, LLC at interest capitalized and added to balance from August 1, 2025; at holder electio maturing maturity extended to earlier of February 13, 2027 or Change in Control.

Instrument
convertible notes
Principal
original principal amounts unchanged (December 2024 Notes); monthly principal repayments of $1,000,000 per month deferre
Counterparty
Kensington Clene 2024, LLC; 4Life Research, LLC; La Scala Investments, LLC
Rate
interest capitalized and added to balance from August 1, 2025; at holder electio
Maturity
maturity extended to earlier of February 13, 2027 or Change in Control
Event
amendment
Exact text from the filing
On August 13, 2025, Clene Inc. (the “Company”) entered into the first amendment (the “Amendment”) to the senior secured convertible promissory notes (collectively, the “December 2024 Notes”) which were issued by the Company on December 17, 2024 to Kensington Clene 2024, LLC (“Kensington”), 4Life Research, LLC (“4Life”) and La Scala Investments, LLC (“La Scala,” and collectively with Kensington and 4Life, the “December 2024 Note Purchasers”).
View on SEC.gov

Browse all debt financings →

Clene Inc. filing history →

Source: SEC EDGAR
accession 0001437749-25-026690
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.